Key result
Postoperative cholesterol crystal embolization triggers fatal pancreatic necrosis and septic shock after total arch replacement.
Case Report (n=1)
No
Cholesterol crystal embolization should be considered in the differential diagnosis of unexplained, recurrent, or progressive pancreatitis following cardiovascular or aortic surgery, as it can lead to fatal extensive pancreatic necrosis and occult multiorgan ischemia.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to fatal embolization-induced pancreatic necrosis after arch replacement; leaves open incidence, prevention, and management strategies.
INTRODUCTION: Acute pancreatitis is a recognized but uncommon complication of cardiovascular surgery. Cholesterol crystal embolization (CCE), a systemic ischemic disease, is a rare and potentially overlooked cause of pancreatic injury after cardiovascular surgery. Pancreatic involvement is uncommon, particularly when it progresses to extensive pancreatic necrosis requiring surgery. In this study, we report a case of CCE presenting as recurrent pancreatitis after total arch replacement that progressed to extensive pancreatic ischemic necrosis requiring total pancreatectomy. CASE PRESENTATION: A 56-year-old man underwent total arch replacement for thoracic aortic aneurysm and subsequently developed acute pancreatitis with hepatic and renal dysfunction. Although his condition initially improved with conservative management, the pancreatitis recurred approximately 2 months after surgery and progressed to extensive, treatment-refractory pancreatic necrosis. He was referred to our institution approximately 4 months after surgery. CT revealed marked diffuse pancreatic enlargement with patchy low-attenuation areas, findings suggestive of extensive pancreatic necrosis. Because of persistent inflammation, disseminated intravascular coagulation, and deterioration of his general condition, total pancreatectomy was performed as a life-saving measure. Histopathological examination revealed widespread pancreatic necrosis and numerous cholesterol crystal emboli in small intrapancreatic arteries, thus establishing the diagnosis of pancreatic ischemic necrosis caused by CCE. On POD 20, the patient developed hemorrhage from the gastroduodenal artery. Although hemostasis was achieved by transcatheter arterial embolization, the patient subsequently developed septic shock and died on POD 22. Autopsy revealed ascending colon necrosis with cholesterol crystal emboli in small arteries and widespread CCE in other organs, including liver, kidneys, stomach, small intestine, and adrenal glands, demonstrating multiorgan involvement of CCE. CONCLUSIONS: CCE should be considered in the differential diagnosis of unexplained, recurrent, or progressive pancreatitis following cardiovascular surgery or endovascular intervention. Furthermore, multiorgan involvement demonstrated at autopsy highlights that CCE presenting predominantly with pancreatic involvement may also affect other organs, warranting careful assessment for additional organ involvement.
No takes yet. Share an insight, caveat, or question.
Ami et al. (2026) conducted a case report in Pancreatic ischemic necrosis caused by cholesterol crystal embolization following total arch replacement (n=1). Cholesterol crystal embolization after total arch replacement treated with total pancreatectomy was evaluated on Histopathological diagnosis and clinical outcome following total pancreatectomy. Cholesterol crystal embolization after total arch replacement caused extensive pancreatic necrosis requiring total pancreatectomy, with fatal septic shock on POD 22 from multiorgan emboli.
Synapse has enriched 10 related papers. Consider them for comparative context: